Evidence map›Paper›PMID 31052484›Full record

ArticleInternational journal of molecular sciences2019

Anti-Cancer Activity of Novel Dihydrotestosterone-Derived Ring A-Condensed Pyrazoles on Androgen Non-Responsive Prostate Cancer Cell Lines.

Gergő Mótyán, Mohana Krishna Gopisetty, Réka Eleonóra Kiss-Faludy, Ágnes Kulmány, István Zupkó, Éva Frank, Mónika Kiricsi

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Gergő MótyánDepartment of Organic Chemistry, University of Szeged, Dóm tér 8, H-6720 Szeged, Hungary. motyan@chem.u-szeged.hu.
Mohana Krishna GopisettyDepartment of Biochemistry and Molecular Biology, University of Szeged, Közép fasor 52., H-6726 Szeged, Hungary. gmohanakrishna@bio.u-szeged.hu.ORCID 0000-0002-4310-3478
Réka Eleonóra Kiss-FaludyDepartment of Organic Chemistry, University of Szeged, Dóm tér 8, H-6720 Szeged, Hungary. elara.elinor.95@gmail.com.
Ágnes KulmányDepartment of Pharmacodynamics and Biopharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary. kulmany.agnes@gmail.com.
István ZupkóDepartment of Pharmacodynamics and Biopharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary. zupko@pharm.u-szeged.hu.ORCID 0000-0003-3243-5300
Éva FrankDepartment of Organic Chemistry, University of Szeged, Dóm tér 8, H-6720 Szeged, Hungary. frank@chem.u-szeged.hu.ORCID 0000-0002-1332-0551
Mónika KiricsiDepartment of Biochemistry and Molecular Biology, University of Szeged, Közép fasor 52., H-6726 Szeged, Hungary. kiricsim@bio.u-szeged.hu.
University of Szeged · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regioselective synthesis of novel ring A-fused arylpyrazoles of dihydrotestosterone (DHT) was carried out in two steps under facile reaction conditions. Aldol condensation of DHT with acetaldehyde afforded a 2-ethylidene derivative regio- and stereo-selectively, which was reacted with different arylhydrazines in the presence of iodine via microwave-assisted oxidative cyclization reactions. The 17-keto analogs of steroidal pyrazoles were also synthesized by simple oxidation in order to enlarge the compound library available for pharmacological studies and to obtain structure-activity relationship. The antiproliferative activities of the structurally related heteroaromatic compounds were tested in vitro on human cervical and breast adenocarcinoma cell lines (HeLa, MCF-7 and MDA-MB-231) and on two androgen-independent malignant prostate carcinoma cell lines (PC-3 and DU 145). Based on primary cytotoxicity screens and IC

Indexed as

AndrogensAntineoplastic AgentsCell Line, TumorCell ProliferationDihydrotestosteroneHumansMaleModels, MolecularProstatic NeoplasmsPyrazolesAndrogensAntineoplastic AgentsDihydrotestosteronePyrazolesanti-cancer effectapoptosisdihydrotestosteroneheterocyclizationprostate cancerpyrazolesregioselectivity

Identifiers

PMID31052484
PMCPMC6539495
OpenAlexW2942662149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.